[1]Tsuchida A,Kasuya K,Endo M,et alHigh risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation\[J\]Oncol Rep,2003,10:1183
[2]Hasumi A,Matsui H,Sugioka A,et alPrecancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction:reappraisal of nationwide survey in Japan\[J\]J Hepatobiliary Pancreat Surg,2000,7:551
[3]张斌,李长锋,杨蕾,等胰胆管合流异常和胆道肿瘤的关系\[J\]中国实验诊学,2007,11:1124
[4]韩新巍,李臻,张伟胰胆管合流异常与胆系癌的相关性探讨\[J\]中国肿瘤临床,2008,35(17):971
[5]Funabiki T,Matsubara T,Miyakawa S,et alPancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy\[J\]Langenbecks Arch Surg,2009,394:159
[6]Tashiro S,Imaizumi T,Ohkawa HOverall report on the registration study of the Japanese study group on pancreaticobiliary maljunction for the past 10 years\[M\]In:Koyanagi Y,Aoki T,editorsPancreaticobiliary maljunctionTokyo:Igaku Tosho,2002:401
[7]Matsubara T,Sakurai Y,Zhi LZ,et alK\|ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction\[J\]J Hepatobiliary Pancreat Surg,2002,9:312
[8]Akihiko Tsuchida,Takao ItoiCarcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction\[J\]World J Gastrointest Oncol,2010,2(3):130
[9]Hanada K,Itoh M,Fujii K,et alK\|ras and P53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct\[J\]Cancer,1996,77:452
[10]Nagai M,Watanabe M,Iwase T,et alClinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction\[J\]World J Surg,2002,26:91
[11]Nagai M,Kawarada Y,Watanabe M,et alAnalysis of microsatellite instability,TGF\|beta type II receptor gene mutations and hMSH2 and hMLH1 allele losses in pancreaticobiliary maljunction\|associated biliary tract tumors\[J\]Anticancer Res,1999,19:1765
[12]Kawakita H,Tsuchida A,Miyazawa K,et alGrowth inhibitory effects of vitamin K2 on colon cancer cell lines via different types of cell death including autophagy and apoptosis\[J\]Int J Mol Med,2009,23:709
[13]Iwamoto J,Matsumoto H,Takeda TEfficacy of menatetrenone (vitamin K2) against non\|vertebral and hip fractures in patients with neurological diseases:meta\|analysis of three randomized,controlled trials\[J\]Clin Drug Investig,2009,29:471
[14]Tsuchida A,Itoi T,Kasuya K,et alInhibitory effect of meloxicam,a cyclooxygenase\|2 inhibitor,on N\|nitrosobis (2\|oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters\[J\]Carcinogenesis,2005,26:1922
|